SCHEDULE 13D

Company

Oncotelic Therapeutics, Inc.

Filed

October 10, 2008

Accession Number

0000950142-08-001663

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →